International Journal of Innovative Approaches in Science Research
Abbreviation: IJIASR | ISSN (Print): 2602-4810 | ISSN (Online): 2602-4535 | DOI: 10.29329/ijiasr

Original article    |    Open Access
International Journal of Innovative Approaches in Science Research 2022, Vol. 6(3) 133-144

Contribution of Self-Lymphatic Drainage to Subclinical Lymphedema After Treatment for Breast Cancer

Engin Taştaban

pp. 133 - 144   |  DOI: https://doi.org/10.29329/ijiasr.2022.474.1

Published online: September 30, 2022  |   Number of Views: 6  |  Number of Download: 39


Abstract

Lymphedema is a significant complication of breast cancer treatment. Early treatment of subclinical lymphedema may prevent its related complications. We aimed to evaluate the contribution of applying self-lymphatic drainage (SLD) in subclinical LE patients. One hundred twenty-eight women diagnosed with subclinical lymphedema were enrolled in the study. Patients were allocated into control group 1 (n=64) and SLD group 2 (n=64). Excess volume; the Visual Analog Scale (VAS) for pain, stiffness, heaviness, and tightness; the Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH) for disability; handgrip strength; Beck Depression Inventory (BDI) for depression were recorded before and after therapy. Statistically significant improvements in the excess volume were observed in both groups; however, there was a substantial change in the SLD group. Also, only the VAS and BDI scores were assessed significantly lower in the SLD group than in the control group. In conclusion, SLD is useful in reducing lymphedema volume, sensations of pain, stiffness, heaviness, tightness, and depression in patients with subclinical LE.

Keywords: Subclinical Lymphedema, Self-Lymphatic Drainage, Breast Cancer


How to Cite this Article

APA 6th edition
Tastaban, E. (2022). Contribution of Self-Lymphatic Drainage to Subclinical Lymphedema After Treatment for Breast Cancer . International Journal of Innovative Approaches in Science Research, 6(3), 133-144. doi: 10.29329/ijiasr.2022.474.1

Harvard
Tastaban, E. (2022). Contribution of Self-Lymphatic Drainage to Subclinical Lymphedema After Treatment for Breast Cancer . International Journal of Innovative Approaches in Science Research, 6(3), pp. 133-144.

Chicago 16th edition
Tastaban, Engin (2022). "Contribution of Self-Lymphatic Drainage to Subclinical Lymphedema After Treatment for Breast Cancer ". International Journal of Innovative Approaches in Science Research 6 (3):133-144. doi:10.29329/ijiasr.2022.474.1.

References
  1. Bahtiyarca, Z. T., Can, A., Eksioglu, E., & Cakci, A. (2019). The addition of self-lymphatic drainage to compression therapy instead of manual lymphatic drainage in the first phase of complex decongestive therapy for treatment of breast cancer-related lymphedema: A randomized-controlled, prospective study. Turkish journal of physical medicine and rehabilitation, 65(4), 309-317. [Google Scholar]
  2. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of general psychiatry, 4, 561-571. [Google Scholar]
  3. Borman P, Moffatt C, Murray S, Yaman A, Denizli M, Dalyan M, Unsal-Delialioğlu S, Eyigör S, Ayhan F, Çakıt BD, Vural S, Özdemir O, Kurt E, Çelik EC, Cerrahoğlu L, Kepekçi M, Terzioğlu F, & Donmez AA. (2019). LIMPRINT Study: The Turkish Experience. Lymphatic research and biology, 17(2), 202-210. [Google Scholar]
  4. Boyages, J., Vicini, F. A., Shah, C., Koelmeyer, L. A., Nelms, J. A., & Ridner, S. H. (2021). The Risk of Subclinical Breast Cancer-Related Lymphedema by the Extent of Axillary Surgery and Regional Node Irradiation: A Randomized Controlled Trial. International journal of radiation oncology, biology, physics, 109(4), 987-997. [Google Scholar]
  5. Brown, J. C., Cheville, A. L., Tchou, J. C., Harris, S. R., & Schmitz, K. H. (2014). Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema. Support Care Cancer, 22(1), 135-143. [Google Scholar]
  6. Bucci, L. K., Brunelle, C. L., Bernstein, M. C., Shui, A. M., Gillespie, T. C., Roberts, S. A., Naoum, G. E., & Taghian, A. G. (2021). Subclinical Lymphedema After Treatment for Breast Cancer: Risk of Progression and Considerations for Early Intervention. Annals of surgical oncology, 28(13), 8624-8633. [Google Scholar]
  7. Cansiz, G., Arikan Donmez, A., Kapucu, S., & Borman, P. (2022). The effect of a self-management lymphedema education program on lymphedema, lymphedema-related symptoms, patient compliance, daily living activities and patient activation in patients with breast cancer-related lymphedema: A quasi-experimental study. European journal of oncology nursing, 56, 102081. [Google Scholar]
  8. Damstra, R. J., Halk, A. B., & Dutch Working Group on, L. (2017). The Dutch lymphedema guidelines based on the International Classification of Functioning, Disability, and Health and the chronic care model. Journal of vascular surgery, 5(5), 756-765. [Google Scholar]
  9. DiSipio, T., Rye, S., Newman, B., & Hayes, S. (2013). Incidence of unilateral arm ref after breast cancer: a systematic review and meta-analysis. The Lancet. Oncology, 14(6), 500-515. [Google Scholar]
  10. Dixon, J. B., & Weiler, M. J. (2015). Bridging the divide between pathogenesis and detection in lymphedema. Seminars in cell & developmental biology, 38, 75-82. [Google Scholar]
  11. Donmez, A. A., & Kapucu, S. (2017). The effectiveness of a clinical and home-based physical activity program and simple lymphatic drainage in the prevention of breast cancer-related lymphedema: A prospective randomized controlled study. European journal of oncology nursing, 31, 12-21. [Google Scholar]
  12. Executive Committee of the International Society of Lymphology (2020). The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology, 53(1), 3–19. [Google Scholar]
  13. Fish, M. L., Grover, R., & Schwarz, G. S. (2020). Quality-of-Life Outcomes in Surgical vs Nonsurgical Treatment of Breast Cancer-Related Lymphedema: A Systematic Review. JAMA surgery, 155(6), 513-519. [Google Scholar]
  14. Gencay Can, A., Eksioglu, E., & Cakci, F. A. (2019). Early Detection and Treatment of Subclinical Lymphedema in Patients with Breast Cancer. Lymphatic research and biology, 17(3), 368-373. [Google Scholar]
  15. LeBlanc, M., Stineman, M., DeMichele, A., Stricker, C., & Mao, J. J. (2014). Validation of QuickDASH outcome measure in breast cancer survivors for upper extremity disability. Archives of physical medicine and rehabilitation, 95(3), 493-498. [Google Scholar]
  16. Levenhagen, K., Davies, C., Perdomo, M., Ryans, K., & Gilchrist, L. (2017). Diagnosis of Upper Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of the American Physical Therapy Association. Physical therapy, 97(7), 729-745. [Google Scholar]
  17. Martins da Silva, R. C., & Rezende, L. F. (2014). Assessment of impact of late postoperative physical functional disabilities on quality of life in breast cancer survivors. Tumori, 100(1), 87-90. [Google Scholar]
  18. Merchant, C. R., Chapman, T., Kilbreath, S. L., Refshauge, K. M., & Krupa, K. (2008). Decreased muscle strength following management of breast cancer. Disability and rehabilitation, 30(15), 1098-1105. [Google Scholar]
  19. Ochalek, K., Gradalski, T., & Partsch, H. (2017). Preventing Early Postoperative Arm Swelling and Lymphedema Manifestation by Compression Sleeves After Axillary Lymph Node Interventions in Breast Cancer Patients: A Randomized Controlled Trial. Journal of pain and symptom management, 54(3), 346-354. [Google Scholar]
  20. Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., Cannady, R. S., Pratt-Chapman, M. L., Edge, S. B., Jacobs, L. A., Hurria, A., Marks, L. B., LaMonte, S. J., Warner, E., Lyman, G. H., & Ganz, P. A. (2016). American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA: a cancer journal for clinicians, 66(1), 43-73. [Google Scholar]
  21. Ryans, K., Perdomo, M., Davies, C. C., Levenhagen, K., & Gilchrist, L. (2021). Rehabilitation interventions for the management of breast cancer-related lymphedema: developing a patient-centered, evidence-based plan of care throughout survivorship. Journal of cancer survivorship. [Google Scholar]
  22. Sezgin Ozcan, D., Dalyan, M., Unsal Delialioglu, S., Duzlu, U., Polat, C. S., & Koseoglu, B. F. (2018). Complex Decongestive Therapy Enhances Upper Limb Functions in Patients with Breast Cancer-Related Lymphedema. Lymphatic research and biology, 16(5), 446-452. [Google Scholar]
  23. Soran, A., Ozmen, T., McGuire, K. P., Diego, E. J., McAuliffe, P. F., Bonaventura, M., Ahrendt, G. M., DeGore, L., & Johnson, R. (2014). The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphatic research and biology, 12(4), 289-294. [Google Scholar]
  24. Stout, N. L., Pfalzer, L. A., Levy, E., McGarvey, C., Springer, B., Gerber, L. H., & Soballe, P. (2011). Segmental limb volume change as a predictor of the onset of lymphedema in women with early breast cancer. PM&R, 3(12), 1098-1105. [Google Scholar]
  25. Tastaban, E., Soyder, A., Aydin, E., Sendur, O. F., Turan, Y., Ture, M., & Bilgen, M. (2020). Role of intermittent pneumatic compression in the treatment of breast cancer-related lymphoedema: a randomized controlled trial. Clinical rehabilitation, 34(2), 220–228. [Google Scholar]
  26. Temur, K., & Kapucu, S. (2019). The effectiveness of lymphedema self-management in the prevention of breast cancer-related lymphedema and quality of life: A randomized controlled trial. European journal of oncology nursing, 40, 22-35. [Google Scholar]
  27. Williams, A. F., Vadgama, A., Franks, P. J., & Mortimer, P. S. (2002). A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedema. European journal of cancer care, 11(4), 254-261. [Google Scholar]
  28. Yamamoto, T., & Koshima, I. (2013). Subclinical lymphedema: understanding is the clue to decision making. Plastic and reconstructive surgery, 132(3), 472e-473e. [Google Scholar]
  29. Yamamoto, T., Matsuda, N., Doi, K., Oshima, A., Yoshimatsu, H., Todokoro, T., Ogata, F., Mihara, M., Narushima, M., Iida, T., & Koshima, I. (2011). The earliest finding of indocyanine green lymphography in asymptomatic limbs of lower extremity lymphedema patients secondary to cancer treatment: the modified dermal backflow stage and concept of subclinical lymphedema. Plastic and reconstructive surgery, 128(4), 314e-321e. [Google Scholar]
  30. Zhang, X., Oliveri, J. M., & Paskett, E. D. (2020). Features, Predictors, and Treatment of Breast Cancer-related Lymphedema. Current breast cancer reports, 12(4), 244-254. [Google Scholar]
  31. Zhao, H., Wu, Y., Zhou, C., Li, W., Li, X., & Chen, L. (2021). Breast cancer-related lymphedema patient and healthcare professional experiences in lymphedema self-management: a qualitative study. Supportive care in cancer, 29(12), 8027-8044. [Google Scholar]